These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2077866)

  • 21. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research and development strategies, examples among new vaccines].
    Denis F; Ploy MC
    Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biotechnology and animal health].
    Desmettre P
    Rev Sci Tech; 1993 Jun; 12(2):355-68. PubMed ID: 8400382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced efficacy of CTLA-4 fusion anti-caries DNA vaccines in gnotobiotic hamsters.
    Zhang F; Li YH; Fan MW; Jia R; Xu QA; Guo JH; Yu F; Tian QW
    Acta Pharmacol Sin; 2007 Aug; 28(8):1236-42. PubMed ID: 17640488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do we need a newer generation of recombinant vaccines against hepatitis B?
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1997 Dec; 92(12):2314-5. PubMed ID: 9399785
    [No Abstract]   [Full Text] [Related]  

  • 26. The issue of new generation vaccines. Hierarchy of the risk.
    Vannier P
    Dev Biol Stand; 1992; 79():99-104. PubMed ID: 1286771
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.
    March JB; Clark JR; Jepson CD
    Vaccine; 2004 Apr; 22(13-14):1666-71. PubMed ID: 15068849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New vaccines against hepatitis B.
    Papaevangelou G
    Chemioterapia; 1987 Jun; 6(2 Suppl):650-2. PubMed ID: 2978391
    [No Abstract]   [Full Text] [Related]  

  • 32. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.
    Ambrosch F; Frisch-Niggemeyer W; Kremsner P; Kunz C; André F; Safary A; Wiedermann G
    Postgrad Med J; 1987; 63 Suppl 2():129-35. PubMed ID: 3317348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral therapeutic vaccination with Streptococcus sobrinus recombinant enolase confers protection against dental caries in rats.
    Dinis M; Tavares D; Veiga-Malta I; Fonseca AJ; Andrade EB; Trigo G; Ribeiro A; Videira A; Cabrita AM; Ferreira P
    J Infect Dis; 2009 Jan; 199(1):116-23. PubMed ID: 18956975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Humoral immunological response in laboratory animals after vaccination with recombinant vaccines against viral hepatitis B of different generations].
    Górska P
    Przegl Epidemiol; 2007; 61(2):393-400. PubMed ID: 17956059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
    Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
    Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.